ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages ASP Isotopes Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ASPI

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of ASP Isotopes Inc. securities during the specified Class Period, alleging misleading statements by the company regarding its technology and operational results [1][5]. Group 1: Class Action Details - The class action lawsuit is on behalf of investors who purchased ASP Isotopes securities between October 30, 2024, and November 26, 2024 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by submitting a form or contacting the law firm directly [3][6]. Group 2: Allegations Against ASP Isotopes - The lawsuit claims that ASP Isotopes overstated the effectiveness of its enrichment technology and the development potential of its uranium facility [5]. - It is alleged that the company misrepresented the results of its nuclear fuels operating segment, leading to materially misleading statements about its business and prospects [5]. - The lawsuit asserts that when the true information became public, investors suffered damages [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].